Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis
Cancer Biotherapy and Radiopharmaceuticals · 01.11.2020 · 35 (9) · 640-649
DOI: 10.1089/cbr.2019.3318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, erschienen am 01.11.2020. Verfasst von Xiaojuan Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China.
Zitieren
APA
Liu, X., Xie, S., Zhang, J., & Kang, Y. (2020). Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis. Cancer Biotherapy and Radiopharmaceuticals, 35(9), 640-649. https://doi.org/10.1089/cbr.2019.3318
Vancouver
Liu X, Xie S, Zhang J, Kang Y. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis. Cancer Biotherapy and Radiopharmaceuticals. 2020;35(9):640-649. doi:10.1089/cbr.2019.3318
BibTeX
@article{Liu2020,
author = {Liu, Xiaojuan and Xie, Shuangshuang and Zhang, Jing and Kang, Yanhua},
title = {Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2020},
volume = {35},
number = {9},
pages = {640--649},
doi = {10.1089/cbr.2019.3318}
}
EUVIMED